← Leaderboards
Amanda Johnson
Johns Hopkins University
$197,384
Attributed
$197,384
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $99.2K · FY2023–25$100K$75K$50K$25K$0
'23
'24
'25
Funding mix
By agency
NIH$197,384 · 2
By mechanism
K00$99,216 · 1
F99$98,168 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Philip C Wong$27,601,264
- Stuart S Martin$11,571,187
- Christopher A Ross$35,771,871
- Barbara Stauch Slusher$18,499,514
- Philip A Cole$22,629,551
Others in their field
Other Rising Stars on “Inhibitor”
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Michael Difilippantonio · Leidos Biomedical Research, Inc.$22,364,766
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Michael George Natchus · Emory University$10,548,554
- John Alam · Eip Pharma, Inc.$10,411,018
- Kenneth Schultz · Trethera Corporation$8,384,949
Research focus
InhibitorMolecularHeterogeneityImmunotherapyIn VivoMalignant NeoplasmsGlioblastomaGliomaImmuneImmunosuppressionCoculture TechniquesIn VitroAnti-Tumor Immune ResponseMalignant Neoplasm Of BrainAdultGeneticBioinformaticsCell PhysiologyCellsClinical TranslationImmune Checkpoint InhibitorImmune EvasionAttenuatedNeoplastic Cell
Grant awards (3)
Defining Therapeutically Targetable Regulators of Tumor-Intrinsic Immune Suppression in Glioblastoma$99,216
K00 · FY2025 · CA · contact PI
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM$48,974
F99 · FY2024 · CA · contact PI
Dissecting the tumor cell-immune TME axis to identify therapeutically actionable vulnerabilities that potentiate immunotherapy in GBM$49,194
F99 · FY2023 · CA · contact PI